Dr. Gabriel is currently serving as Chief Executive Officer, CEO, for BioMedInnovations, LLC. Denver, North Carolina. Most recently he operated as Vice President of Equity Research at H.C. Wainwright & Co., covering the most relevant HealthCare biotech firms with a focus on Respiratory, Allergenic and Immunologic indications. Previously, he served as Vice President of Scientific Search and Alliance Management at Nivalis Therapeutics, a clinical-stage biotechnology company focused on developing transformational medications for patients with Cystic Fibrosis, (CF). In that role Dr. Gabriel was responsible for overseeing the preclinical development of Nivalis products as well as conducting diligence and evaluation of other products and potential collaborators (Biotech and Academic) in the CF space. During his tenure with Nivalis, Dr. Gabriel was a fundamental part of the Executive team that successfully completed both a cross-over and IPO round of funding as well as an IND submission. Prior to Nivalis Dr. Gabriel was a Professor of Pediatrics, at the University of North Carolina at Chapel Hill and Director of the Cystic Fibrosis Molecular Therapy and Correction Core. He also served as Co-chairman and founding member of the Cystic Fibrosis Foundation, CFF, Mucociliary Clearance Consortium.
Ms. Carrie DiMarzio has formally been COO of BioMedInnovations, LLC since 2019, and informally COO since 2015. Ms. DiMarzio has learned about, been involved with, and managed every aspect of BMI’s corporate development since her start with BMI. Current and prior experience includes formally being CEO of Industrial Hard Carbon, LLC (IHC) for two years, a specialty surface modification and thin film coating service provider, having been CEO informally while General Manager for seven years. Prior relevant business experience is primarily in marketing and sales. Ms. DiMarzio has the 10,000 foot vision, commitment to match, and attention to detail on the ground to execute on the vision with excellent people skills.
Tony Arndt is VP of Engineering and has been involved in all aspects of CaVESWave® software development, system integration, automation and commercial design for production. Mr. Arndt earned a BSEE specializing in automation from UNC-Charlotte after having studied Applied Science of Radio Communications Technology in the Air Force early in his career. Six years’ immediate prior experience at Industrial Hard Carbon, LLC, Denver NC is that of Automation Engineer including complex production equipment and facilities. Mr. Arndt has owned and operated his Company, Technical Advantage, for nearly 30 years. Mr. Arndt’s broad, well rounded, electrical, mechanical, software and automation experience serves BMI’s startup position well.
Sherif Gabriel Ph.D. BiomedInnovations (LLC)
919-260-9762
info2019@BioMedInnovationsLLC.com
Carrie DiMarzio BiomedInnovations (LLC)
704-999-5897
info2019@BioMedInnovationsLLC.com
CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential